Clinical Trial Update: (mo)BETTA Trial in Transwomen for Optimization of ART [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the moBETTA trial in transwomen for optimization of ART, terminated with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: HIV Infections | Phase 4 | Status: TERMINATED | Results posted: 2022-10-03